FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Janssen Pharmaceuticals Risperdal CONSTA Recall

Risperdal CONSTA (risperiDONE), 25 mg Dose Pack, Rx Only, Single Use Only Janssen Pha…

Janssen Pharmaceuticals, Inc. · Titusville, NJ

Risk level
Class II
Reported by FDA
Aug 13, 2014
Recall ID
D-1514-2014
Check your lot numberHow we source this data

Summary

Janssen Pharmaceuticals recalled Risperdal CONSTA starting Sep 11, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1514-2014 on Aug 13, 2014. Reason: Non-Sterility: Janssen is recalling one lot of Risperdal CONSTA (risperiDONE) due to a sterility failure in a stability sample. Status: Terminated.

Why it was recalled

Non-Sterility: Janssen is recalling one lot of Risperdal CONSTA (risperiDONE) due to a sterility failure in a stability sample

Product description

Risperdal CONSTA (risperiDONE), 25 mg Dose Pack, Rx Only, Single Use Only Janssen Pharmaceuticals Inc., Titusville, NJ 08560 NDC 50458-306-11

Lot numbers, UPCs & expiration codes

Vial - 4212AAP1, Kit - 309316, Exp. 07/15

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1514-2014
Classification
Class II
Status
Terminated
Recall initiated
Sep 11, 2013
FDA report date
Aug 13, 2014
Quantity
70,495 kits
Recall type
Voluntary: Firm initiated
Recalling firm
Janssen Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-1514-2014, exactly as published.

Show all FDA fields
City
Titusville
State
NJ
Status
Terminated
Country
United States
Event ID
66261
Address
1125 Trenton Harbourton Rd
Code information
Vial - 4212AAP1, Kit - 309316, Exp. 07/15
Postal code
08560-1503
Report date
Aug 13, 2014
Product type
Drugs
Recall number
D-1514-2014
Classification
Class II
Recalling firm
Janssen Pharmaceuticals, Inc.
Product quantity
70,495 kits
Termination date
Jan 23, 2015
Reason for recall
Non-Sterility: Janssen is recalling one lot of Risperdal CONSTA (risperiDONE) due to a sterility failure in a stability sample
Voluntary / mandated
Voluntary: Firm initiated
Product description
Risperdal CONSTA (risperiDONE), 25 mg Dose Pack, Rx Only, Single Use Only Janssen Pharmaceuticals Inc., Titusville, NJ 08560 NDC 50458-306-11
Distribution pattern
Nationwide
Recall initiation date
Sep 11, 2013
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Aug 5, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1514-2014, published Aug 13, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls